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Aim: The rheological properties of erythrocytes are impaired in diabetes mellitus, especially 
because of changes in their membrane lipid composition.The aim of this study was to deter-
mine and examine the relationship between red blood cell (RBC) membrane and serum lipid 
composition in type II diabetes subjects with and without nephropathy.
Methods: Trinidadian subjects aged 18–65 years were recruited for the study regardless of 
gender and ethnicity. Fasting blood samples were collected from 60 subjects of whom 20 were 
healthy individuals, 20 had type II diabetes without complications, and 20 were type II diabet-
ics with nephropathy. Weight, height, waist/hip ratio, and blood pressure were recorded. All 
the blood samples were analysed to determine the serum lipid concentration, membrane lipid 
composition and plasma glucose concentration.
Results: The body mass index and the systolic blood pressure of the diabetics (28.17 ± 4.98 kg/m2, 
153.21 ± 22.10 mmHg) and those with nephropathy (25.87 ± 4.68, 158.60 ± 22.49 mmHg) 
were higher when compared with controls (24.67 ± 5.18, 119.15 ± 13.03 mmHg). The diabetic 
(175.89 ± 102.73 μg/mgprotein) and diabetic nephropathy (358.80 ± 262.66) subjects showed 
signiﬁ  cantly higher levels of RBC membrane cholesterol compared with controls (132.27 ± 
66.47). The membrane phospholipids, protein and Na+/K+ATPase concentrations were altered 
in diabetics and diabetic nephropathy patients when compared with controls. The trends of 
increased serum cholesterol and decreased high-density lipoprotein in diabetics and diabetic 
nephropathy patients were noted as compared with controls but they are not signiﬁ  cant as 
expected. The low-density lipoprotein cholesterol was signiﬁ  cantly higher in diabetics when 
compared with diabetic nephropathy and control subjects.
Conclusions: Our data suggest that there is a relationship between RBC membrane and 
serum lipid composition in subjects with type II diabetes with and without nephropathy. This 
relationship shows that diet and lifestyle plays a signiﬁ  cant role in the alterations of the lipids 
both in serum and RBC membrane. The membrane and serum lipid composition may be used 
as possible indicators for type II diabetic patients with and without nephropathy to control their 
diet in the beginning stages to prevent them from further complications.
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Introduction
Diabetes mellitus is a chronic metabolic disease, characterized by hyperglycemia 
with disturbances of carbohydrate, protein and fat metabolism due to an absolute or 
relative deﬁ  ciency of insulin (Barcelo and Rajpathak 2001). Type II diabetes mellitus 
results from a combination of defective insulin secretion and insulin resistance, almost 
certainly involving the insulin receptor. Diabetic nephropathy is a syndrome occur-
ring in people with diabetes mellitus, characterized by albuminuria, hypertension, and 
progressive renal insufﬁ  ciency (Stedmans 2005).Vascular Health and Risk Management 2008:4(4) 894
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Diabetes mellitus is one of the most prevalent diseases in 
the developing world and the urgency for its management is 
increasing as the number of cases in these countries grows 
each year. In 2006, according to the World Health Organiza-
tion (WHO), at least 171 million people worldwide suffered 
from diabetes and this ﬁ  gure is expected to double by the 
year 2030 (WHO 2007). Globally type II diabetes mellitus 
is the 3rd and 10th leading cause of loss of years of potential 
life among women and men respectively (Boyne et al 2006). 
A study done in 2001 among people 35–64 years old found 
that in Trinidad and Tobago, over 10% of the population had 
diabetes (Barcelo and Rajpathak 2001).
The red cell membrane contains approximately equal 
amounts of lipids and proteins. Membrane lipids are 
either phospholipids or neutral lipids, mostly unesteriﬁ  ed 
cholesterol. Membrane phospholipids are asymmetrically 
arranged into a lipid bilayer two molecules thick. Choline 
phospholipids are more abundant in the extracellular surface 
whereas amino phospholipids are more concentrated on 
the inner leaﬂ  et of the bilayer. Cholesterol is intercalated 
between the phospholipid molecules. The relative amounts 
of cholesterol and phospholipids are responsible for the 
ﬂ  uid properties of the erythrocyte membrane (Ballas and 
Krasnow 1980; Nagle and Tristram-Nagle 2000). Alterations 
in the membrane cholesterol-phospholipid ratio result in 
morphologically abnormal erythrocytes with decreased life 
span. Alterations in blood rheological properties have been 
reported in poorly controlled diabetes mellitus (Bryszewska 
et al 1986; Miossec et al 1999). Changes in lipid composi-
tion of RBC membranes resulting in an impairment of RBC 
deformability may play a role in an altered blood rheologi-
cal pattern (Bakan et al 2006). There are few reports on the 
relationship between serum and RBC membrane lipid com-
position in other populations. Lee and colleagues (2004) 
showed that diet and general health status has close relation 
to the ﬂ  ow behavior of blood, which inﬂ  uences the circulation 
of the blood in the body. In their study they demonstrated 
that the high level of cholesterol, low-density lipoprotein 
(LDL) and high-density lipoprotein (HDL) in vivo alter 
the morphology and ﬂ  ow behavior of blood cells that can 
subsequently increase the risk of impairing physical func-
tion and microcirculation (Lee et al 2004). The present study 
has sought to determine and examine the relationship of the 
RBC membrane and serum lipid composition in Trinidadian 
type II diabetes with or without nephropathy (between the 
ages of 18–65 yrs). In addition, it has sought to determine 
the relationship between the RBC membrane and serum 
lipid composition in noninsulin-dependent diabetes mellitus 
(NIDDM) patients in the multiethnic population of Trinidad, 
a third world country in the Americas.
This study has aimed to establish a link between the lipid 
composition of the RBC membrane and serum to aid in the 
early diagnosis and treatment of patients with type II diabetes 
mellitus, thus preventing the development of further compli-
cations including the impaired RBC deformability.
Methods
Research design and method
The objective of this case control study was to determine 
the impact of type II diabetes mellitus on RBC membrane 
and serum lipid composition among individuals between the 
ages of 18 and 65 in Trinidad. The study includes 60 sub-
jects (male and female regardless of ethnicity) of which 20 
were healthy individuals, 20 patients were type II diabetes, 
and 20 patients had type II diabetes and nephropathy.
The patients were recruited from the diabetic and nephrol-
ogy clinic of various regional health centers of Trinidad 
and Tobago. The diabetics were selected on the basis of 
their fasting blood glucose value. The urea, creatinine, and 
microalbumin values were considered for including diabetic 
nephropathy patients in our study. The study was approved 
by the Ethics Committee for human experimentation 
(EC 59: 07/07-05/06), The Faculty of Medical Sciences, The 
University of the West Indies, St. Augustine. The blood pres-
sure, height, weight (and resultant body mass index [BMI]), 
hip circumference, and waist circumference (and resultant 
waist/hip ratio) of all participants were recorded. Data was 
also collected by taking blood samples from which the fol-
lowing outcome attributes were measured: plasma glucose, 
serum total cholesterol, triglyceride (TG), LDL, HDL, RBC 
membrane composition (cholesterol, proteins, phospholipids, 
ATPase) and blood glucose.
Determination of serum lipid 
composition
The fasting blood sugar cholesterol, TG, HDL, and LDL 
cholesterol were estimated by fully automated analyzer 
(Vitros 250; Ortho-Clinical Diagnostics Inc., Rochester, 
NY, USA).
Estimation of RBC membrane 
compositions
Processing of RBC
The blood collected in purple colored tube was centrifuged 
for 10 minutes and the supernatant (plasma) was discarded. 
Two mL of normal saline was added to the tubes, mixed and Vascular Health and Risk Management 2008:4(4) 895
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centrifuged at 5000 g for 10 minutes. The supernatant was 
decanted and this procedure was repeated twice. Then 0.1mL 
tris HCl buffer, pH 7.4 (isotonic) was added and centrifuged 
for 5 minutes. This procedure was repeated three times. The 
clear cells obtained were suspended in a hypotonic buffer 
and stored at 4 ˚C for four hours. Afterwards the cells were 
washed again with hypotonic buffer and then centrifuged at 
15,000 g and 10,000 g for 30 and 20 minutes, respectively. 
This procedure was continued until the solution became col-
orless. Two drops of isotonic buffer were added to the solu-
tion and it was homogenized to get the red cell membrane. 
This was used for the extraction lipids and determination of 
protein and Na+K+ATPase estimation.
Extraction of lipids
The red cell membrane collected was again centrifuged for 
10 minutes at 15,000 g. The supernatant was decanted and 
the pellet obtained was suspended in 1 ml of methanol and 
homogenized. The solution was made up to 5 ml with the same 
methanol and centrifuged for 15 minutes at the same speed. 
The supernatant was decanted, added 14 ml of chloroform to 
the tube and transferred in to a ﬂ  at bottom ﬂ  ask. The content 
of this ﬂ  ask was evaporated in a fume hood. To the evapo-
rated content, added 5 ml of chloroform- methanol mixture 
to dissolve the solid and the resulting solution is poured into 
a labeled centrifuge tube and covered with parafﬁ  n. These 
tubes are centrifuged at 6000 rpm and two differed layers of 
ﬂ  uid were visible. The upper aqueous layer was aspirated and 
discarded while the lower layer was retained for lipid testing 
(Folch et al 1957). Aliquots of this layer were used for the 
estimation of cholesterol, phospholipids, and TG.
Membrane cholesterol
Lipid extract of 0.6 ml was evaporated. Different standard 
concentrations ranging from 20, 40, 60, 80, 100, and 120 μg 
was used. Each standard of 0.05 mL was transferred from 
respective tubes to the tubes labeled S1 to S6 and evaporated. 
To these tubes (including the test) was added 3 ml of ferric 
acetate uranyl acetate. The blank was run simultaneously. 
Sulphuric acid ferrous sulphate 2 ml was added and the con-
tents were mixed properly. The tubes were left standing for 
20 minutes and their color intensity was read at 560 nm. The 
cholesterol concentration of the test sample was determined 
using a standard graph plotted (Parekh and Jung 1970).
Membrane phospholipids
Lipid extract of 0.6 ml was evaporated in a fume hood. 
Standard phosphate solutions of ﬁ  ve different concentrations 
were used. A blank was run simultaneously. To all the tubes 
added 1 ml of perchloric acid, 0.5 ml of 3% ammonium 
molybdate (freshly prepared), and 0.5 ml ascorbic acid 
(freshly prepared). The total volume of all the tubes was 
made up to 6 ml with deionised water. All tubes were kept 
in boiling water for 6 minutes and the blue color developed 
was red at 710 nm. The phospholipid concentration of the 
test sample was determined using a standard graph plotted 
(Rouser et al 1970).
Membrane Na+K+ATPase
The membrane collected was used for the Na+K+ATPase. 
The membrane was made up to 1 ml with isotonic buffer and 
added 0.2 ml of 50 mM MgSO4, 50 mM KCl, 1 mM EDTA, 
and 40 mM ATP solution. Blank was run along with it which 
contained the entire reagent except the red cell membrane. 
The tubes were equilibrated at 37 °C for 10 minutes. To all 
the tubes added 0.1 ml of enzyme solution at intervals of 
3 minutes and the tubes were incubated at 37 °C for one hr 
in a water bath. After one hour, 1 ml of ice cold 10% TCA 
and 0.1ml of ANSA was added. The blue color developed 
was read at 620 nm. The Na+K+ATPase concentration of 
the test sample was determined using a standard graph 
(Bonting 1970).
Membrane protein
Membrane suspension of 0.1 ml was made up to 1.0 ml with 
deionised water. 5.0 ml of alkaline copper reagent was added, 
mixed well and allowed to stand for 10 minutes at room 
temperature. Standards solutions of bovine serum albumin 
range from 10–100 μg and blank containing 1 ml water were 
treated similarly. Folin-Ciocalteu reagent of 0.5 ml was added 
very rapidly and mixed immediately. After two minutes the 
blue color developed was read at 640 nm. Protein concentra-
tions were expressed in mg/ml of the membrane preparation 
(Lowry et al 1951).
Sample speciﬁ  cation
The target population for this study consisted of individu-
als between the age of eighteen to sixty ﬁ  ve years each, 
regardless of gender and race residing in Trinidad. There 
are three groups: A – control (healthy individuals); B – type 
II diabetics without nephropathy; and C – type II diabetics 
with nephropathy.
Individuals for group A were chosen from those 
patients screened at the diabetic clinics and proven to be 
healthy. Individuals for group B were chosen from those 
patients attending the diabetic clinics at the three previously Vascular Health and Risk Management 2008:4(4) 896
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mentioned hospitals. Individuals for group C were chosen 
from those patients attending the nephrology clinic at the 
same hospitals.
Statistics and calculations
Results were expressed as mean ± standard deviation. Data 
were analyzed using the Statistical Package for Social Sci-
ence (version 12.0; SPSS Inc., Chicago, IL, USA). The 
sample size calculated for this study was 22 per group, 
however due to logistic limitations we were only able to 
obtain 20 samples per group and hence the sample size used 
was 20. The comparisons within and among groups were 
done using Student’s paired t- test and independent samples 
t-test. The p value 0.05 was taken as the cut off level for 
signiﬁ  cance. Pearson’s correlation test was used to examine 
correlation.
Results
Table 1 and bar diagrams show the anthropometric and bio-
chemical values for the three groups of subjects. The body 
mass index and the systolic blood pressure of the diabetics 
(28.17 ± 4.98 kg/m2, 153.21 ± 22.10 mmHg) and nephropathic 
diabetics (25.87 ± 4.68 kg/m2, 158.60 ± 22.49 mmHg) were 
higher compared with controls (24.67 ± 5.18 kg/m2, 119.15 ± 
13.03 mmHg). The diabetic (175.89 ± 102.73 μg/mg/protein) 
and diabetic nephropathy (358.80 ± 262.66 μg/mg/protein) 
subjects showed significantly higher levels of RBC 
membrane cholesterol compared with controls (132.27 ± 
66.47 μg/mgprotein) (Figure 1). The membrane phospholip-
ids, protein and Na+/K+ATPase concentrations for controls 
were: (9.17 ± 9.23 μg/mgprotein, 0.94 ± 0.47 mg/mL, 0.021 ± 
0.021 μmoles/ml) for diabetics: (5.31 ± 4.51 μg/mg protein, 
0.65 ± 0.38 mg/mL, 0.026 ± 0.039 μmoles/ml), nephropathic 
diabetics: ( 19.67 ± 14.83 μg/mg protein, 1.19 ± 0.79 mg/mL, 
0.023 ± 0.020 μmoles/ml), respectively (Figure 2). The trend 
of increased serum cholesterol and decreased HDL in diabetics 
(206.85 ± 47.34 mg/dL, 43.45 ± 9.45 mg/dL) and those with 
nephropathy (209.90 ± 66.13 mg/dL, 41.60 ± 9.23 mg/dL) 
were compared with controls (184.50 ± 35.69 mg/dL, 
48.05 ± 12.42) but were not signiﬁ  cant as expected. The LDL 
cholesterol was signiﬁ  cantly higher in diabetics (131.00 ± 
35.63 mg/dL) when compared with those with nephropathy 
(116.40 ± 54.03 mg/dL) and the control subjects (118.70 ± 
37.75 mg/dL).
The correlation between waist/hip ratio and blood 
pressure in diabetics and diabetics with nephropathy was 
not signiﬁ  cant (Figure 3). There was an increase in the 
means of serum cholesterol in diabetics and diabetics with 
nephropathy, however there were no signiﬁ  cant relation-
ship when diabetics and diabetics with nephropathy were 
compared to controls (p = 0.611 and p = 0.415, respectively) 
(Figure 4).
The mean values of RBC membrane cholesterol showed 
the same increase as serum cholesterol; however the 
relationship for this variable between controls and diabetics 
is not signiﬁ  cant (p = 0.514) whereas, the relationship for this 
variable between diabetics and diabetics with nephropathy is 
signiﬁ  cant (p = 0.023) (Figure 5). The RBC membrane protein 
mean values was lower in diabetics (0.65 ± 0.38) compared 
with controls and a larger value in diabetics with nephropathy 
(1.19 ± 0.79) compared with controls (0.94 ± 0.47). The mean 
reading of Na+/K+ATPase activity was higher in diabetics with 
Table 1 Means and standard deviations for the variables tested for controls, diabetics and diabetics with nephropathy
Variable  Controls    Diabetics   Diabetes with nephropathy 
 (Mean  ± SD)   (Mean ± SD)   (Mean ± SD) 
 n  = 20  n = 20  n = 20
Body mass index (Kg/m2) 24.67  ± 5.18  28.17 ± 4.98  25.87 ± 4.68
Waist/hip ratio  0.85 ± 0.06  0.87 ± 0.07  0.91 ± 0.07
Systolic blood pressure(mmHg)  119.15 ± 13.03  153.21 ± 22.10  158.60 ± 22.49
Diastolic blood pressure(mmHg)  76.80 ± 7.65  94.93 ± 10.62  90.30 ± 13.61
Glucose (mg/100 mL)   83.25 ± 6.29  120.55 ± 41.20  105.20 ± 37.64
Figure 1 Graph showing membrane cholesterol means amongst the three groups.
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nephropathy (0.023 ± 0.020) and much higher in diabetics 
(0.031 ± 0.039) when compared with controls (0.021 ± 0.021). 
The mean readings of RBC membrane phospholipids showed 
a decrease in diabetics (5.31 ± 4.51) but an increase in diabet-
ics with nephropathy (19.67 ± 14.83) when compared with 
controls (9.17 ± 8.23).
The means of LDL showed an increase in diabetics 
(131.00 ± 35.63) and a decrease in diabetics with nephropathy 
(116.40 ± 54.03) when compared with controls (118.70 ± 
37.75) (Figure 6). The mean HDL readings decreased in dia-
betics (43.45 ± 9.45) and more in diabetics with nephropathy 
(41.60 ± 9.23) when compared with controls (48.05 ± 12.42) 
(Figure 6).
Discussion
The increase in body mass index and waist/hip ratio was 
expected since obesity is a known risk factor of diabetes. 
Blood pressure was also elevated in the diabetic group as 
compared to controls since increased blood pressure, in 
diabetics, is correlated with increased waist circumference. 
Blood pressure was elevated in diabetics with nephropathy 
because angiopathy of renal glomeruli is an associated 
pathology.
Higher serum cholesterol in diabetics than controls 
could be attributed to the metabolism of acetate, a precur-
sor to cholesterol, produced in increased amounts from the 
catabolism of fatty acids, carbohydrates and amino acids 
in the diet of this group (Talwar and Srivastava 2003). 
Serum cholesterol level was further elevated in diabetics 
with nephropathy since hypercholesterolemia is a con-
stant feature of nephrotic syndrome (Kumar et al 2003). 
LDL-cholesterol increased in diabetics when compared 
to the control subjects from less than ideal management 
of diabetes, including poor diet control such as high 
intake of saturated fats and carbohydrates without the use 
of statins. In the diabetics with nephropathy the lower 
LDL-cholesterol was thought to be due to better disease 
management in these patients who attend a renal clinic 
and receive specialist attention. Decreased HDL levels in 
diabetics and an even further decrease in diabetics with 
nephropathy can be explained by reduced action of insulin 
at the tissue level and therefore insulin resistance (Valabhji 
and Elkeles 2003).
The increased RBC membrane cholesterol and altered 
phospholipid concentration in diabetics and diabetic nephrop-
athy subjects when compared with controls may explain 
poor metabolic control. The increase in RBC membrane 
cholesterol in diabetics with and without nephropathy appears 
to reﬂ  ect serum cholesterol.
Prisco and colleagues (1989) observed altered levels of 
RBC membrane phosholipid ratio in diabetics which could 
account for the impaired RBC deformability frequently 
reported in diabetes mellitus (Prisco et al 1989). Researchers 
also showed the relationship of altered RBC lipid composi-
tion and rheological impairment of the RBC (Garnier et al 
1990). RBC membrane protein was decreased in diabetics 
when compared with controls and this could be due to 
damage of membrane proteins by nonenzymatic glycation 
Figure 2 Graph showing red blood cell (RBC) membrane phospholipids means 
amongst the three groups.
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Figure 3 Graph showing comparison between systolic blood pressure (BP) and waist/hip ratio means amongst the three groups.
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(Sampietro et al 1986; Watala et al 2005). In vitro studies of 
researchers demonstrated the decreased lipid ﬂ  uidity in dia-
betics caused by nonenzymatic glycation of RBC membrane 
proteins (Watala 1988). RBC membrane protein was higher 
in the cases of diabetics with nephropathy, possibly due to 
the altered, healthier diets that diabetics with nephropathy 
are strictly advised to adhere to. Such diets would ensure 
that glucose levels were maintained within limits, thereby 
reducing RBC deformability. The decrease in membrane 
phospholipids in diabetics could have occurred from damage 
induced by nonenzymatic glycosylation of the cell mem-
brane and subsequent loss of phospholipids from the RBC 
membrane (Ellenberg and Rifkin 1983). The management 
of diet and better disease control could have resulted in 
increased membrane phospholipids in the diabetics with 
nephropathy. Miossec and colleagues (1999) investigated 
the relationship between erythrocyte deformability, plasma 
lipids, lipid membrane composition, and cytosolic cations in 
poorly controlled type 2 diabetic patients and they concluded 
that in poorly controlled type 2 diabetic patients there is a 
link between the chemical composition and the rheological 
properties of erythrocytes.
Our data suggest that there is a relationship between RBC 
membrane and serum lipid composition in subjects with type 
II diabetes with and without nephropathy. This relationship 
shows that diet and lifestyle plays a signiﬁ  cant role in the 
alterations of the lipids both in serum and RBC membrane. 
Diet and management of diabetes plays a signiﬁ  cant role not 
only in altering the lipid proﬁ  le but also preventing rheologi-
cal impairment of the RBC.
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Figure 4 Graph showing serum cholesterol means amongst the three groups.
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Figure 6 Graph showing comparison between HDL and LDL means amongst the 
three groups.
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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